Sign In
Buy FC
$23.30
-0.640 (-2.67%)
At Close: Jun 03, 2026
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
10:01am, Wednesday, 27'th May 2026
[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for people living wi
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
10:00am, Wednesday, 27'th May 2026
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for people living with gastrointestinal (GI) and
80% of Individual Contributors Say Their Manager's Approach to AI is Hands-Off, FranklinCovey Research Finds
01:00pm, Thursday, 21'st May 2026
As organizations race to capture the benefits of artificial intelligence, research from [url="]FranklinCovey[/url] Institute reveals a critical obstacle: most
80% of Individual Contributors Say Their Manager's Approach to AI is Hands-Off, FranklinCovey Research Finds
12:38pm, Thursday, 21'st May 2026
SALT LAKE CITY--(BUSINESS WIRE)-- #AI--As organizations race to capture the benefits of artificial intelligence, research from FranklinCovey Institute reveals a critical obstacle: most employees feel
Diploma H1 Earnings Call Highlights
05:07am, Tuesday, 19'th May 2026
Diploma LON: DPLM reported what management described as a “very strong” first half for the six months ended March 31, 2026, with double-digit organic growth, higher margins and upgraded full-year
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
03:00pm, Sunday, 17'th May 2026
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that full results of its ADVANCE OUTCOMES study are being present
TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC, FC.DB. K, FC.DB. L and FC.DB.M) today released its financial statements for the
Franklin Covey Q2 Earnings Call Highlights
03:07am, Friday, 03'rd Apr 2026
Franklin Covey (NYSE: FC) executives said the company's fiscal second quarter 2026 results showed continued momentum from its go-to-market changes in Enterprise North America, with invoiced amounts ri
Top 2 Industrials Stocks You May Want To Dump In Q2
12:12pm, Thursday, 02'nd Apr 2026
As of April 2, 2026, two stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Franklin Covey Co. (FC) Q2 2026 Earnings Call Transcript
09:02pm, Wednesday, 01'st Apr 2026
Franklin Covey Co. (FC) Q2 2026 Earnings Call Transcript
Franklin Covey (FC) Reports Q2 Loss, Tops Revenue Estimates
06:25pm, Wednesday, 01'st Apr 2026
Franklin Covey (FC) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of breakeven. This compares to a loss of $0.08 per share a year ago.
Franklin Covey Reports Second Quarter Fiscal 2026 Financial Results
04:12pm, Wednesday, 01'st Apr 2026
SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a global leadership and organizational performance partner, gives strategy the human edge. We help clients achieve breakthrough results
SALT LAKE CITY--(BUSINESS WIRE)-- #CNO--FranklinCovey Provides Customized Solutions for Healthcare Organizations to Solve Key Issues: Nurse Retention and Patient Satisfaction.
Franklin Covey: What I'm Looking For In Q2 Earnings
11:13am, Thursday, 26'th Mar 2026
Despite the recent fundamental declines, I believe Franklin Covey remains structurally attractive with material untapped TAM despite that should prevail past recent weakness. I'll be watching for cont
Should Value Investors Buy Franklin Covey (FC) Stock?
10:42am, Thursday, 26'th Mar 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
